doi: 10.1136/bmj.o1037.
Covid-19: What is the evidence for the antiviral Paxlovid?
Affiliations
- PMID: 35477536
- DOI: 10.1136/bmj.o1037
Item in Clipboard
Covid-19: What is the evidence for the antiviral Paxlovid?
BMJ.
.
No abstract available
Conflict of interest statement
Competing interests: I have read and understood the BMJ policy on declaration of interests and have no relevant interests to declare.
Similar articles
-
COVID-19 update: Prescription of Paxlovid by pharmacists.Med Lett Drugs Ther. 2022 Aug 8;64(1656):e124. Med Lett Drugs Ther. 2022. PMID: 35921075 No abstract available.
-
Paxlovid for treatment of COVID-19.Med Lett Drugs Ther. 2022 Jan 24;64(1642):9-10. Med Lett Drugs Ther. 2022. PMID: 35134040 No abstract available.
-
Exploring Paxlovid Efficacy in COVID-19 Patients with MAFLD: Insights from a Single-Center Prospective Cohort Study.Viruses. 2024 Jan 12;16(1):112. doi: 10.3390/v16010112. Viruses. 2024. PMID: 38257811 Free PMC article.
-
Small-molecule anti-COVID-19 drugs and a focus on China's homegrown mindeudesivir (VV116).Front Med. 2023 Dec;17(6):1068-1079. doi: 10.1007/s11684-023-1037-3. Epub 2024 Jan 2. Front Med. 2023. PMID: 38165534 Review.
-
The need for a multi-level drug targeting strategy to curb the COVID-19 pandemic.Front Biosci (Landmark Ed). 2021 Dec 30;26(12):1723-1736. doi: 10.52586/5064. Front Biosci (Landmark Ed). 2021. PMID: 34994185 Review.
Cited by
-
Clinical Effectiveness of Ritonavir-Boosted Nirmatrelvir-A Literature Review.Adv Respir Med. 2024 Jan 18;92(1):66-76. doi: 10.3390/arm92010009. Adv Respir Med. 2024. PMID: 38247553 Free PMC article. Review.
-
Analyzing the Difference in the Length of Stay (LOS) in Moderate to Severe COVID-19 Patients Receiving Hydroxychloroquine or Favipiravir.Pharmaceuticals (Basel). 2022 Nov 24;15(12):1456. doi: 10.3390/ph15121456. Pharmaceuticals (Basel). 2022. PMID: 36558907 Free PMC article.
-
Anticipating the Next Chess Move: Blocking SARS-CoV-2 Replication and Simultaneously Disarming Viral Escape Mechanisms.Genes (Basel). 2022 Nov 18;13(11):2147. doi: 10.3390/genes13112147. Genes (Basel). 2022. PMID: 36421821 Free PMC article.
-
Small molecules in the treatment of COVID-19.Signal Transduct Target Ther. 2022 Dec 5;7(1):387. doi: 10.1038/s41392-022-01249-8. Signal Transduct Target Ther. 2022. PMID: 36464706 Free PMC article. Review.
-
Effectiveness of molnupiravir vs nirmatrelvir-ritonavir in non-hospitalised and hospitalised patients with COVID-19: a target trial emulation study.EClinicalMedicine. 2023 Sep 20;64:102225. doi: 10.1016/j.eclinm.2023.102225. eCollection 2023 Oct. EClinicalMedicine. 2023. PMID: 37753272 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
